XML 36 R27.htm IDEA: XBRL DOCUMENT v3.23.2
Basis of Presentation and Summary of Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2023
Accounting Policies [Abstract]  
Schedule of Revenue Disaggregated by Product and Service Type

The following table shows revenue disaggregated by product and service type for the three and six months ended June 30, 2023 and 2022 (in thousands):

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Scilex Pharmaceuticals Inc. product sales

 

$

12,582

 

 

$

7,926

 

 

$

23,164

 

 

$

14,738

 

Sorrento Therapeutics, Inc. product revenues

 

 

23

 

 

 

665

 

 

 

38

 

 

 

3,844

 

Net product revenues

 

$

12,605

 

 

$

8,591

 

 

$

23,202

 

 

$

18,582

 

Concortis Biosystems Corporation

 

$

1,773

 

 

$

1,983

 

 

$

4,780

 

 

$

6,617

 

Bioserv Corporation

 

 

388

 

 

 

592

 

 

 

1,059

 

 

 

1,467

 

Other service revenues

 

 

259

 

 

 

295

 

 

 

2,235

 

 

 

3,179

 

Service revenues

 

$

2,420

 

 

$

2,870

 

 

$

8,074

 

 

$

11,263